Crazy Taxi: World Tour is coming to PS5, PC, Nintendo Switch 2, and Xbox Series X/S in 2027, SEGA has announced. Building on the gameplay of the classic Crazy Taxi games on arcade and Dreamcast, this ...
b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.
This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.
Experience a detailed performance review of the latest generation utility vehicle designed to dominate both daily commutes and unpredictable terrains. This breakdown highlights the transition to a ...
NBC Selected independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Cory Fernandez Commerce Editor Summer is almost here ...
Initial phase 1b/2 study results of purinostat mesylate (PM) in combination with pomalidomide (POM) and low dexamethasone (DEX) in patients with RRMM. This is an ASCO Meeting Abstract from the 2026 ...
After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...
REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE)-- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...
PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...
WAUKEE – Chicago Cubs minor-league pitcher Tyler Ras stands to the side of the indoor baseball field at SportsPlex West on a January evening, tossing balls to high school players on the club team, the ...
Democrats believe they now have “multiple paths” to flipping the Senate this year, touting strong recruits in some deep red states and a message focused on costs and health care. And, for the first ...